MSB 4.69% $1.45 mesoblast limited

"ARDS is very much bigger than COVID-19 and will continue well...

  1. 337 Posts.
    lightbulb Created with Sketch. 113
    "ARDS is very much bigger than COVID-19 and will continue well beyond the time any vaccine becomes available for one of the many causes of ARDS."

    I really think this is the kicker @Treed. COVID is all-consuming at the moment, and everyone is seeing everything through this lens (for many stocks - biotech, online retail, streaming). But one eye has to stay on the future and a world where COVID isn't king anymore. Surely.

    The treatment's potential is huge. That's what's exciting.
    Last edited by trader1221: 19/08/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.